These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1516624)

  • 21. Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen.
    Pinet V; Malnati MS; Long EO
    J Immunol; 1994 May; 152(10):4852-60. PubMed ID: 8176208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
    Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
    Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 envelope protein is expressed on the surface of infected cells before its processing and presentation to class II-restricted T lymphocytes.
    Callahan KM; Rowell JF; Soloski MJ; Machamer CE; Siliciano RF
    J Immunol; 1993 Sep; 151(6):2928-42. PubMed ID: 8376762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cells.
    Adorini L; Ullrich SJ; Appella E; Fuchs S
    Nature; 1990 Jul; 346(6279):63-6. PubMed ID: 2366863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficient generation and expansion of antigen-specific CD4+ T cells by recombinant influenza viruses.
    Nimmerjahn F; Kobelt D; Steinkasserer A; Menke A; Hobom G; Behrends U; Bornkamm GW; Mautner J
    Eur J Immunol; 2003 Dec; 33(12):3331-41. PubMed ID: 14635041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting major histocompatibility complex class II molecules to the cell surface by invariant chain allows antigen presentation upon recycling.
    Nijenhuis M; Calafat J; Kuijpers KC; Janssen H; de Haas M; Nordeng TW; Bakke O; Neefjes JJ
    Eur J Immunol; 1994 Apr; 24(4):873-83. PubMed ID: 8149958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
    Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
    J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recognition of pre-processed endogenous antigen by class I but not class II MHC-restricted T cells.
    Sweetser MT; Morrison LA; Braciale VL; Braciale TJ
    Nature; 1989 Nov; 342(6246):180-2. PubMed ID: 2478887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
    Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
    J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T cells specific for different antigens express different HLA-D region products.
    Schendel DJ; Johnson JP
    Eur J Immunol; 1985 Dec; 15(12):1239-43. PubMed ID: 3878791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DR alpha beta dimers released from complexes with invariant chain fail to stimulate alloreactive T cell clones.
    Demotz S
    Eur J Immunol; 1993 Sep; 23(9):2100-8. PubMed ID: 8370392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-surface expression of human histocompatibility leucocyte antigen (HLA) class II-associated invariant chain (CD74) does not always correlate with cell-surface expression of HLA class II molecules.
    Wilson KM; Labeta MO; Pawelec G; Fernandez N
    Immunology; 1993 Jun; 79(2):331-5. PubMed ID: 8344710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of antigen presentation of influenza A nucleoprotein expressed in attenuated AroA- Salmonella typhimurium with that of live virus.
    Brett SJ; Rhodes J; Liew FY; Tite JP
    J Immunol; 1993 Apr; 150(7):2869-84. PubMed ID: 7681081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells.
    Jaraquemada D; Marti M; Long EO
    J Exp Med; 1990 Sep; 172(3):947-54. PubMed ID: 2388037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule.
    Chen BP; Madrigal A; Parham P
    J Exp Med; 1990 Sep; 172(3):779-88. PubMed ID: 2117634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I- and class II-restricted cytotoxic T cell recognition.
    van Binnendijk RS; van Baalen CA; Poelen MC; de Vries P; Boes J; Cerundolo V; Osterhaus AD; UytdeHaag FG
    J Exp Med; 1992 Jul; 176(1):119-28. PubMed ID: 1613454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding of radioiodinated influenza virus peptides to class I MHC molecules and to other cellular proteins as analyzed by gel filtration and photoaffinity labeling.
    Reyes VE; Lu S; Humphreys RE
    Mol Immunol; 1991; 28(4-5):341-8. PubMed ID: 2062316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Class II major histocompatibility complex-restricted T cells specific for a virion structural protein that do not recognize exogenous influenza virus. Evidence that presentation of labile T cell determinants is favored by endogenous antigen synthesis.
    Eisenlohr LC; Hackett CJ
    J Exp Med; 1989 Mar; 169(3):921-31. PubMed ID: 2784481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient class II major histocompatibility complex presentation of endogenously synthesized hepatitis C virus core protein by Epstein-Barr virus-transformed B-lymphoblastoid cell lines to CD4(+) T cells.
    Chen M; Shirai M; Liu Z; Arichi T; Takahashi H; Nishioka M
    J Virol; 1998 Oct; 72(10):8301-8. PubMed ID: 9733874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presentation of a cytosolic antigen by major histocompatibility complex class II molecules requires a long-lived form of the antigen.
    Guéguen M; Long EO
    Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14692-7. PubMed ID: 8962116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.